Scientists launch massive GIST registry to unlock secrets of rare digestive cancer
NCT ID NCT07273045
First seen Dec 16, 2025 · Last updated Jun 20, 2026 · Updated 27 times
Summary
This registry study will collect medical information and biological samples from 1,000 people diagnosed with GIST, a rare digestive tract tumor. It does not test any new treatment—participants continue their usual care. The goal is to better understand how GIST behaves, especially rare forms, and to help design future studies and treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GIST - GASTROINTESTINAL STROMAL TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Essem
Essen, North Rhine-Westphalia, 45147, Germany
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this registry could help researchers identify risk factors and design better treatments for rare forms of GIST.
What could go wrong
This is an observational registry, not a treatment trial. It collects data only and will not directly benefit participants. Results may take years to influence care.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.